AHEP1531: Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

Brief description of study

This trial is the first international cooperative liver tumors trial in which a consensus approach was established by investigators representing Children’s Oncology Group (COG), Société Internationale d’Oncologie Pédiatrique – Epithelial Liver Tumor Study Group (SIOPEL) and the Japanese Children’s Cancer Group (JCCG). The study builds on treatment strategies established by the most recent trials from each of the individual consortia – COG (AHEP0731), SIOPEL (SIOPEL 3 and 4) and Japanese Pediatric Liver Tumor study group (JPLT2), but provides new approaches to all stages of HB and HCC patients keeping the aforementioned goals in focus. A critical aspect of this trial is the opportunity to correlate histologic and biologic heterogeneity with response and outcomes in all risk categories, providing promise for future refinement to the newly proposed risk stratification schema.


Clinical Study Identifier: s19-01611
ClinicalTrials.gov Identifier: NCT03533582
Principal Investigator: Sharon L Gardner.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.